Key result
Review outlines AF mechanisms, risk factors, and stroke and bleeding risk assessment.
This review summarizes the genetic and acquired mechanisms of atrial fibrillation, its classification, and the importance of risk stratification for stroke and bleeding to guide future precision medicine.
Emphasizes stroke and bleeding risk assessment in AF; leaves open genetic-guided precision approaches.
心房細動(atrial fibrillation:AF)は,遺伝的素因に加え,加齢や生活習慣病による後天的素因が複合して発症し,徐々に慢性化していく疾患である.近年のゲノムワイド関連解析(genome-wide association study:GWAS)により,心房細動関連遺伝子が多数発見され,また,発症及び慢性化に重要な心房リモデリングに関するメカニズム解明も進んでおり,今後,これらをもとにしたプレシジョン・メディシンが期待される.心房細動の最大の合併症は心原性脳塞栓であり,塞栓症リスク・出血リスクの評価に基づく抗凝固療法が重要である.
No takes yet. Share an insight, caveat, or question.
Tetsuo Sasano (2019) conducted a review in Atrial Fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: